The PREVENT program is a peer-reviewed agent development program designed to support preclinical development of innovative interventions and biomarkers for cancer prevention and interception towards clinical trials. All interested researchers with novel concepts are eligible to apply. PREVENT is not a grant program, but allocates NCI contract resources and expertise to generate data and materials, which are used by the applicants for further development. PREVENT’s current research priority areas include immunoprevention, chemoprevention, and clinically translatable biomarkers.
Read more About PREVENT.
Application Instructions
Next application deadlines are June 2, 2025, and November 3, 2025.
Please apply using the PREVENT Application System.
Supported Projects
134 Projects from PREVENT Cycles 1 through 26:
- 79 Chemoprevention projects
- 46 Immunoprevention projects
- 9 Biomarker projects
Read more about supported projects and supported prevention approaches.
Available Resources
- Efficacy
- Toxicology
- Regulatory Support
- Current Good Manufacturing Practice (CGMP)
- DCP Repository
Program Administration
- Governance Structure
- Technology Transfer Considerations
News and Events
DCP Participation at the American Association for Cancer Research Annual Meeting
Date Posted: April 25, 2025
Prevention and Screening Drive Drop in Cancer Deaths
Date Posted: January 14, 2025
Biomedical Engineering Society (BMES) 2024 Annual Meeting
Date Posted: October 21, 2024
DCP Participation at Biomedical Engineering Society (BMES) Annual Meeting - October 24, 2024
Date Posted: October 15, 2024
Microbial Host Defense and Effect on Cancer Initiation and Progression
Date Posted: July 11, 2024
Contact the PREVENT team
For application-related, general programmatic inquiries, or if you would like to arrange for a virtual seminar at your organization by one of our PREVENT Program Directors, please contact: NCIDCPPREVENT@mail.nih.gov.